12:00 AM
May 21, 2012
 |  BC Week In Review  |  Company News  |  Deals

Fibrocell, MIT, University of California deal

Fibrocell acquired rights to commercialize discoveries resulting from a 2011 deal with the university to research the conversion of dermal fibroblasts into pure functional human cell types for potential use in personalized medicine for...

Read the full 148 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >